Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 14/20 | 0.69 |
| ▸ | ROCK1 | Q13464 | 12/20 | 0.69 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | PRKACA | P17612 | 2/20 | 0.58 |
| ▸ | PRKX | P51817 | 2/20 | 0.58 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | GSK3A | P49840 | 1/20 | 0.58 |
| ▸ | GSK3B | P49841 | 1/20 | 0.58 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.58 |
| ▸ | AURKA | O14965 | 1/20 | 0.56 |
| ▸ | GRK5 | P34947 | 1/20 | 0.55 |
| ▸ | NAMPT | P43490 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13376861 | 0.85 | ROCK1 (0.65) | ROCK2ROCK1MAPTPRKACACYP3A4 | |
| SCHEMBL18254785 | 0.83 | ROCK2 (0.56) | ROCK2ROCK1ALDH1A1 | |
| SCHEMBL18254887 | 0.82 | ROCK2 (1.00) | ROCK2ROCK1MAPTPRKACAPRKX | |
| SCHEMBL3127521 | 0.81 | ROCK2 (1.00) | ROCK2ROCK1MAPTPRKACAPRKX | |
| SCHEMBL5597604 | 0.80 | ROCK2 (0.54) | ROCK2ROCK1MAPTMEN1ALDH1A1 | |
| SCHEMBL2558208 | 0.80 | ROCK1 (1.00) | ROCK2ROCK1PRKACACYP3A4GSK3B | |
| SCHEMBL24867317 | 0.79 | ROCK1 (0.61) | ROCK2ROCK1MAPTNAMPTMEN1 | |
| SCHEMBL20181387 | 0.79 | ROCK2 (0.55) | ROCK2ROCK1PRKACAPRKXPRKCQ | |
| SCHEMBL18254791 | 0.79 | ROCK2 (0.55) | ROCK2ROCK1PRKACAPRKXPRKCQ | |
| SCHEMBL18254876 | 0.79 | ROCK1 (0.69) | ROCK2ROCK1PRKACAPRKXPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10807966-B2 | Heterocyclic compounds as kinase inhibitors | TRANSLATIONAL DRUG DEVELOPMENT, LLC (US) | 2020-10-20 | — | — | US | disclosed |
| US-20190284157-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | TRANSLATIONAL DRUG DEVELOPMENT, LLC | 2019-09-19 | — | — | US | disclosed |
| WO-2018094362-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | TRANSLATIONAL DRUG DEVELOPMENT, LLC (US) | 2018-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10807966-B2 | Heterocyclic compounds as kinase inhibitors | MAP3K1, MAP3K20, MAP3K5 | ROCK2 76/4885ROCK1 67/4885MAPT 2045/4885 |
| US-20190284157-A1 | HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS | MAP3K1, MAP3K20, MAP3K5 | ROCK2 76/4885ROCK1 67/4885MAPT 2045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.